secwatch.observer — SEC 8-K summary
======================================

Issuer:     BELLICUM PHARMACEUTICALS, INC (—)
CIK:        0001358403
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001628280-23-020109
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellicum Pharmaceuticals receives delisting notice from Nasdaq; to trade on OTCQX
--------------------------------------------------------------------------------

- Nasdaq will suspend trading of BLCM common stock at open on June 2, 2023 due to non-compliance with equity continued listing rule.
- Company did not submit a compliance plan to Nasdaq as required by May 19, 2023.
- No appeal will be filed; common stock to trade on OTCQX marketplace under symbol BLCM.
- Previous disclosure indicated stockholders' equity failed Nasdaq's minimum requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023020109/0001628280-23-020109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023020109/blcm-20230530.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-020109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer